Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Masatoshi Kumagai"'
Autor:
Mika Fukushima, Masaaki Imamura, Masanori Ito, Kei Muraoka, Michiko Fukasawa, Masatoshi Kumagai, Ryo Yabusaki, Masakatsu Ueda, Yusuke Shiraishi, Tetsuya Noguchi, Koji Yoshimura
Publikováno v:
BJUI Compass, Vol 5, Iss 1, Pp 29-33 (2024)
Abstract Objective The objective of this study is to evaluate the need for sterile gloves during cystoscopy by comparing the incidence of UTI symptoms between patients in whom the procedure is performed with non‐sterile gloves with those performed
Externí odkaz:
https://doaj.org/article/5861cd39e6234ca8b5d0059364103240
Autor:
Koji Yoshimura, Kei Muraoka, Michiko Fukasawa, Mika Fukushima, Masatoshi Kumagai, Ryo Yabusaki, Masakatsu Ueda, Yusuke Shiraishi, Masaaki Imamura
Publikováno v:
IJU Case Reports, Vol 5, Iss 4, Pp 273-275 (2022)
Introduction Patients with nonmetastatic but exceptionally high‐risk prostate cancer are liable to have biochemical failure and may even die. Triple combination therapy, which consists of surgery, radiotherapy, and androgen‐deprivation therapy, a
Externí odkaz:
https://doaj.org/article/957d496cd23043c480b38846dc2c27a1
Autor:
Ryo, Yabusaki, Michiko, Fukasawa, Kei, Muraoka, Mika, Fukushima, Masatoshi, Kumagai, Masakatsu, Ueda, Yusuke, Shiraishi, Masaaki, Imamura, Koji, Yoshimura
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 68(6)
We report the use of combination chemotherapy of gemcitabine (800 mg/m² on day1 and 8) and nedaplatin (60 mg/m² on day 1), including neoadjuvant therapy in four cases of squamous cell carcinoma of the urinary tract. In each case, the dose was reduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::38c99054c97bb5fdf8b555780a6f7800
https://pubmed.ncbi.nlm.nih.gov/35850508
https://pubmed.ncbi.nlm.nih.gov/35850508
Autor:
Masatoshi Kumagai, Nobuki Furubayashi, Toshihisa Tomoda, Yoshifumi Hori, Noriaki Tokuda, Motonobu Nakamura, Futoshi Morokuma, Tomohiro Inoue, Takahito Negishi, Kentaro Kuroiwa
Publikováno v:
Journal of Clinical Medicine Research
Background: Since December 2017, pembrolizumab has been approved in Japan as a second-line treatment for radical unresectable urothelial carcinoma (UC) that has become exacerbated after chemotherapy by the international randomized phase 3 trial, KEYN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fa406f68a7b293a2b893a52ec40d2a1
https://doi.org/10.14740/jocmr4162
https://doi.org/10.14740/jocmr4162
Autor:
Futoshi Morokuma, Masatoshi Kumagai, Yoshifumi Hori, Tomohiro Inoue, Nobuki Furubayashi, Takahito Negishi, Toshihisa Tomoda, Kentaro Kuroiwa, Motonobu Nakamura, Noriaki Tokuda
Publikováno v:
Molecular and Clinical Oncology
Pembrolizumab has been available for the treatment of radical resectable urothelial carcinoma (UC) when it is exacerbated after chemotherapy since December 2017 in Japan. However, the efficacy of chemotherapy for cases progressing after pembrolizumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f43c06a09d9d7fd6ab7d09c6c369436
http://europepmc.org/articles/PMC7976390
http://europepmc.org/articles/PMC7976390
Publikováno v:
IEEJ Transactions on Power and Energy. 136:365-372
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eead067fc8019f20ed85e64b1c7be4cb
https://doi.org/10.1541/ieejpes.136.365
https://doi.org/10.1541/ieejpes.136.365
Publikováno v:
ISGT
Online Dynamic Security Assessment (DSA) is a dynamical system widely used for assessing and analyzing an electrical power system. The outcomes of DSA are used in many aspects of the operation of power system, from monitoring the system to determinin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c5765bb3f169f5c33e012a244e4e763
https://doi.org/10.1109/isgt.2017.8086079
https://doi.org/10.1109/isgt.2017.8086079
Autor:
Shinya, Kusumoto, Hiroyuki, Naito, Kunitomo, Imazu, Itsuka, Kai, Aki, Hamasaki, Yoshie, Kazusa, Yumiko, Nakashima, Miho, Kodama, Masatoshi, Kumagai, Katsunori, Ueda
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 44(3)
A standard regimen for ovarian malignant germ cell tumors is bleomycin, etoposide, cisplatin(BEP)chemotherapy. Adherence to a treatment schedule of every 21 days has been reported to be important. However, the incidence of febrile neutropenia( FN)and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ad1aa1fdbb81f542c330eb97eea5ab24
https://pubmed.ncbi.nlm.nih.gov/28292998
https://pubmed.ncbi.nlm.nih.gov/28292998
Publikováno v:
2015 IEEE Power & Energy Society General Meeting.
We developed a constrained state estimation method that clarifies the range of the feeder voltage in an unobservable distribution network in which the number of telemetric sensors is smaller than the number of state variables to be estimated. Instead
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2efe57f4532a9f7df8ed7f0501ea21a
https://doi.org/10.1109/pesgm.2015.7285802
https://doi.org/10.1109/pesgm.2015.7285802
Publikováno v:
IEEJ Transactions on Electronics, Information and Systems. 126:1033-1039
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3373cf33f4c5f516fe4aa2d86ecb20af
https://doi.org/10.1541/ieejeiss.126.1033
https://doi.org/10.1541/ieejeiss.126.1033